Delivery Order SPE2DB22D1202-SPE2DB25FUSH1

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIGIFAB 40 MG VIALS, a medical product, with a ceiling value of $8,748.03. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical product "DIGIFAB 40 MG VIALS" to the Defense Logistics Agency (DLA). The Firm Fixed Price contract is valued at $23,328.08 and has a period of performance through May 24, 2024. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $48,918.25, is a Firm Fixed Price Delivery Order with a completion date of June 12, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a larger Indefinite Delivery Contract (IDC) valued up to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,842.65, is for the supply of DIGIFAB 40 MG VIALS, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,715.72 firm fixed-price delivery order contract is for the supply of DIGIFAB 40 MG VIALS, a medical product. The contract has a performance period through January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,842.65, is for the delivery of 4567089245 DIGIFAB 40 MG VIALS and has an ultimate completion date of January 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
This is a delivery order contract award to AmerisourceBergen Drug Corp for the delivery of DIGIFAB 40 MG VIALS. The contract has a ceiling value of $6,217.46 and is a firm fixed price contract awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of September 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of various medical products and prescription drugs. The contract has a ceiling value of $33,506.48 and an ultimate completion date of August 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSH1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567218379 ! DIGIFAB 40 MG VIALS, with a firm fixed price ceiling value of $60,291.96 and a period of performance through February 11, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:45 AM